Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Safestore non-exec, Eneraqua CEO pick up shares

(Sharecast News) - Safestore was among those at the top of the list of director purchases on Monday, after a non-executive director was involved in picking up more than 12,000 shares. The FTSE 250 self-storage operator said the self-invested pension plan (SIPP) of its senior independent director Ian Krieger bought 12,280 shares on 8 September, in a single transaction on London's main market.

Krieger's SIPP paid 808.8p for each share, valuing the transaction at a total of £99,320.64.

Elsewhere, Eneraqua Technologies was also listed after disclosing the purchase of almost 45,000 shares by its chief executive officer.

The AIM-traded firm Mitesh Dhanak picked up 44,900 shares, also on 8 September, in an off-exchange transaction.

Dhanak paid 102.795p for each share, giving the transaction a total value of £46,154.96.

Eneraqua said that following the purchase, Dhanak and certain parties closely associated with him were interested in 5,817,327 of its ordinary shares, representing 17.55 of its issued share capital.

At 1353 BST, shares in Safestore Holdings were down 0.62% at 800.5p, while those in Eneraqua Technologies were up 15.79% at 110p.

Reporting by Josh White for Sharecast.com.

Top Director Buys

Safestore Holdings (SAFE) Director name: Krieger ,Ian Amount purchased: 12,280 @ 808.80p Value: £99,320.64

Vanquis Banking Group 20 (VANQ) Director name: McLaughlin,Ian Amount purchased: 54,844 @ 109.40p Value: £59,999.34

Eneraqua Technologies (ETP) Director name: Dhanak,Mitesh Ramji Amount purchased: 44,900 @ 102.80p Value: £46,154.96

Taylor Maritime Investments Limited Npv (TMIP) Director name: Dunne ,Frank Amount purchased: 46,389 @ $0.85 Value: $32,514.76

Ecora Resources (ECOR) Director name: Lafleche,Marc Bishop Amount purchased: 12,000 @ 107.61p Value: £12,913.20

Diversified Energy Company (DEC) Director name: Klaber,Kathryn Amount purchased: 11,000 @ 86.40p Value: £9,504.00

Diversified Energy Company (DEC) Director name: Kerrigan,Sylvia Amount purchased: 10,833 @ 86.38p Value: £9,357.55

Diversified Energy Company (DEC) Director name: Stash,Sandra Amount purchased: 10,500 @ 85.79p Value: £9,007.95

Ecora Resources (ECOR) Director name: Flynn,Kevin Amount purchased: 4,700 @ 106.80p Value: £5,019.60

Rolls-royce Holdings (RR.) Director name: Mars,Wendy Amount purchased: 833 @ 218.56p Value: £1,820.60

Allianz Technology Trust (ATT) Director name: Patel,Neeta Amount purchased: 185 @ 267.05p Value: £494.05

Barr (a.g.) (BAG) Director name: Kemp,Jonathan David Amount purchased: 30 @ 494.84p Value: £148.45

Barr (a.g.) (BAG) Director name: Lorimer,Stuart Amount purchased: 30 @ 494.84p Value: £148.45

Barr (a.g.) (BAG) Director name: Barr,Julie A Amount purchased: 30 @ 494.84p Value: £148.45

Barr (a.g.) (BAG) Director name: White,Roger Alexander Amount purchased: 30 @ 494.84p Value: £148.45

The Gym Group (GYM) Director name: Murphy,Ann-marie Amount purchased: 45 @ 111.89p Value: £50.35

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.